Table 1.
miRNA | Attenuation of myocardial injury | Regenerative applications | |||
---|---|---|---|---|---|
Cardiomyocyte apoptosis | Necrosis | Fibrosis | Neovascularization | ||
miR-1 | Repression of antiapoptotic Bcl2 [76], Igf1 [47, 75], Hsp60, Hsp70 [77] | Targeting of profibrotic Fibullin-2 [87] | Enhanced tubulogenesis by repressing Spred-1 [96] | ||
miR-15 | Repression of antiapoptotic Bcl2 [74] | Inhibition of cardiomyocyte proliferation [144, 145] | |||
miR-21 | Protection against apoptosis by targeting Pdcd4 [55, 57, 58] | Reduced necrosis in cultured cardiomyocytes [57] | Promotion of fibroblast proliferation and inhibition of metalloprotease [80, 81, 83], promotion of TGFβ [91] | Improved engraftment of transplanted cardiac progenitor cells [59] | |
miR-24 | Suppression of apoptosis, by repression of Bim [54] | Reduced necrosis in cultured ischemic cardiomyocytes [56] | Decreased fibroblast differentiation and migration by targeting Tgfβ [92] | Inhibition of proangiogenic Gata2 and Pak4 [101] | Improved engraftment of transplanted cardiac progenitor cells [59] |
miR-29 | Proapoptotic by targeting Mcl-1 [73] | Targeting of fibrotic proteins[86] | |||
miR-30 | Inhibition of mitochondrial fission by suppressing Drp1 [53] | Decreased production of collagens[85] | |||
miR-34 | Proapoptotic targeting of Pnuts [72] | ||||
miR-92 | Inhibition of the proangiogenic Itga5 [100] | Induction of cardiomyocyte proliferation [151] | |||
miR-101 | Decreased fibroblast proliferation and collagen deposition by targeting Tgf-β signaling [93] | ||||
miR-126 | Increased proliferation and migration of endothelial cells by repressing Spred-1 [95] | Increased angiogenesis after mesenchymal stem cells [97, 98] and endothelial progenitors [99] trasplantation | |||
miR-133 | Repressing proapoptotic Caspase 9 [77] | Decreased production of collagens [85] | Increased regeneration in zebrafish [147] | ||
miR-145 | Attenuation of Calcium overload by repressing CaMKIIδ [113] and Bnip3 [114] | ||||
miR-199 and 590 | Induction of cell cycle reentry [152] | ||||
miR-210 | Inhibition of apoptosis by targeting Ptp1b [64] | Enhanced angiogenesis by repression of Efna3 [62] | Increased engraftment of bone marrow-derived stem cells [65] and increased survival of mesenchymal stem cells [18] | ||
miR-214 | Attenuation of calcium overload by repressing Ncx1 and CaMKIIδ [112] | Attenuation of calcium overload [112] | Inhibition of endothelial cells sprouting [102] | ||
miR-221 | Improved engraftment of transplanted cardiac progenitor cells [59] | ||||
miR-320 | Proapoptotic by targeting Hsp20 [69] | ||||
miR-378 | Targeting antiapoptotic Igf1R [48] but also apoptotic Caspase 3 [78] | Inhibition of necrosis in hypoxic cardiomyocytes [78] | |||
miR-494 | Activation of Akt [79] | Reduced necrotic death after I/R [79] | |||
miR-499 | Inhibition of mitochondrial fission [52] | Increased regenerative potential and differentiation of cardiac progenitors[17] | |||
miR-711 | Targeting Sp1, reducing collagen production[88] |
Detrimental effects are shown in italics